ClinicalTrials.Veeva

Menu

Probiotics in Primary Care

Penn State Health logo

Penn State Health

Status

Completed

Conditions

Antibiotic Side Effect

Treatments

Dietary Supplement: Probiotic

Study type

Interventional

Funder types

Other

Identifiers

NCT01254097
Probiotic-1

Details and patient eligibility

About

Antibiotics are lifesaving medicines and generally safe, yet unwanted side effects are common. While destroying illness-causing 'bad' bacteria, antibiotics can upset the protective 'good' bacteria in the body. This research will test if taking a probiotic with prescribed antibiotics will decrease the chance of having bothersome antibiotic-associated side effects.

Full description

Objectives Several studies have demonstrated that probiotics can be helpful in preventing antibiotic-associated diarrhoea in hospitalized patients. However, the extent to which probiotics may benefit healthy adults taking a course of antibiotics has not been investigated in primary care. Furthermore, patient willingness to take a probiotic supplement concomitantly with antibiotics has not been explored. We aimed to conduct an exploratory study using probiotics in adults requiring an acute course of antibiotic therapy.

Methods Patients prescribed antibiotics for treatment of acute infections in an outpatient family practice setting were randomized to receive either a probiotic or placebo concurrently. Patients completed adherence diaries and daily symptom checklists to assess gastrointestinal and vaginal (women) symptoms and collect information about adherence.

Enrollment

51 patients

Sex

All

Ages

18 to 79 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adults 18 - 79 years of age with infection requiring an oral antibiotic.
  • Must be able to be contacted via telephone.

Exclusion criteria

  • pregnancy,
  • breast-feeding,
  • those receiving tube feeding,
  • those with diarrhea as a current symptom of present illness, and pre-existing illnesses that contribute to diarrhea such as inflammatory bowel disease,
  • irritable bowel syndrome, colitis or celiac disease.
  • Those undergoing active cancer treatments with chemotherapeutic or radiation therapy,
  • immunocompromised persons,
  • history of cardiac valvular disease,
  • those taking a laxative or stool softener on a daily basis, as well as
  • persons treated with an antibiotic in the previous 60 days,
  • new antibiotic prescription that exceeds a 10 day course, or regular use of a probiotic within the previous three weeks (including daily ingestion of yogurt).

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Double Blind

51 participants in 2 patient groups, including a placebo group

Probiotic
Placebo Comparator group
Description:
Participants are provided in double blinded fashion, probiotic given to take with antibiotics prescribed by their provider.
Treatment:
Dietary Supplement: Probiotic
Placebo
Placebo Comparator group
Description:
Participants are provided in double blinded fashion, Look alike placebo given to take with antibiotics prescribed by their provider.
Treatment:
Dietary Supplement: Probiotic

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems